OSS vs REGN · rev $54.7M vs P/E 14, rev $14.34B
One Stop Systems Inc (OSS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
One Stop Systems Inc (OSS) is a computer hardware company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported OSS revenue for 2024-12-31 was $54.7M. Net income was -$13.6M. Revenue was down 10.2% from 2023-12-31 to 2024-12-31. OSS currently screens at market cap $450.3M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
OSS currently screens at market cap $450.3M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the OSS and REGN stock pages for the full models.
Not investment advice.